Keyphrases
1000 Genomes Project
7%
Acute Lymphoblastic Leukemia
6%
Acute Myeloid Leukemia
15%
Aneuploidy
6%
Breast Cancer
16%
Cancer Drivers
6%
Cancer Genes
9%
Cancer Genome
19%
Cancer Genome Atlas
40%
Cancer Genomics
7%
Cancer Types
44%
Clear Cell Renal Cell Carcinoma (ccRCC)
9%
Clinically Significant
7%
Clonal Architecture
7%
Comprehensive Characterization
8%
Copy number
9%
Copy number Variation
16%
Diacylglycerol Kinase
7%
DNA Methylation (DNAm)
7%
DNA Sequencing
16%
Driver mutations
13%
Druggability
7%
Endometrial Carcinoma
6%
Epigenetics
6%
Gene Expression
13%
Gene Fusion
7%
Genetic Modification
17%
Genome Analysis
15%
Genome Sequencing
9%
Genomic Analysis
6%
Genomic Characterization
10%
Genomic Landscape
15%
Germ Cells
10%
Germline Variants
6%
Glioblastoma
10%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
8%
Helix
7%
High-risk Human Papillomavirus (HR-HPV)
6%
Human Cancer
33%
Human Genome
18%
In Cancer
54%
Leukemia
8%
Long Non-coding RNA (LncRNA)
6%
Lung Adenocarcinoma
11%
Massively Parallel Sequencing
6%
Melanoma
9%
Memory-like
11%
Microenvironment
10%
MicroRNA
7%
Microsatellite Instability-high (MSI-H)
7%
Molecular Characterization
17%
Molecular Features
7%
Multiple Myeloma
9%
Multiple Scattering
18%
Mutated Genes
6%
Myelodysplastic Syndrome
6%
Natural Killer Cells
29%
Near-edge X-ray Absorption Fine Structure (NEXAFS)
17%
Non-coding
7%
Oncogene
6%
Ovarian Cancer
6%
Pan-cancer
22%
Pan-cancer Analysis
54%
Pancreatic Cancer
8%
Pancreatic Ductal Adenocarcinoma
10%
Path Analysis
7%
Patient-derived Xenograft
17%
Pediatric
7%
Primary Tumor
8%
Proteogenomics
46%
Proteomic Analysis
11%
Proteomics
13%
RNA Pseudoknot
7%
RNA Sequencing (RNA-seq)
8%
Sequence Data
14%
Shotgun Sequencing
6%
Signaling Pathway
6%
Single nucleotide Polymorphism
6%
Single nucleotide Variant
7%
Single-cell RNA Sequencing (scRNA-seq)
7%
Somatic Alterations
6%
Somatic mutation
29%
Structural Variants
20%
Structural Variation
12%
TP53 mutation
7%
Transcriptome
7%
Transcriptomics
6%
Tumor
95%
Tumor Cells
8%
Tumor Evolution
7%
Tumor Microenvironment
6%
Tumor Protein p53 (TP53)
11%
Tumor Samples
10%
Tumor Subtype
18%
Tumorigenesis
9%
Virus
6%
Whole Exome Sequencing
11%
Whole Genome
52%
Whole Genome Sequencing
25%
Whole-genome Sequence Data
10%
Biochemistry, Genetics and Molecular Biology
Allele
10%
Alpha Thalassemia/Mental Retardation X-Linked
7%
Aneuploidy
9%
Bioinformatics
7%
BRCA1
6%
Cancer Cell
13%
Cancer Genome Sequencing
5%
Cancer Genomics
8%
Carcinogenesis
23%
Chromosome Instability
6%
Colon
7%
Deep Sequencing
13%
DNA Methylation
17%
DNA Sequence
25%
Enhancer Region
5%
Epidermal Growth Factor Receptor
15%
Epigenetics
17%
Evolution
8%
Exome
13%
Exome Sequencing
16%
Exon
9%
Gene Amplification
5%
Gene Dosage
7%
Gene Expression
23%
Gene Frequency
6%
Gene Fusion
12%
Gene Mutation
21%
Genetic Divergence
11%
Genetic Variation
7%
Genetics
34%
Genome Sequencing
5%
Genomics
100%
Germ Cell
20%
Germline
20%
Haplotype
5%
Hepatitis B Virus
5%
Human Genome
23%
Immunity
23%
Immunocompetent Cell
7%
Indel
19%
Kinase
10%
KRAS
8%
Long Non-Coding RNA
8%
Loss of Heterozygosity
5%
Mass Spectrometry
5%
Messenger RNA
17%
Metabolic Pathway
7%
Methylation
8%
MicroRNA
14%
Microsatellite Instability
5%
Missense
5%
Mutated Genes
13%
Mutation Rate
8%
Myeloid
26%
Natural Killer Cell
10%
Next Generation Sequencing
11%
Oncogene
15%
Pan-cancer
44%
Phosphoproteomics
5%
Phosphotransferase
10%
Point Mutation
6%
Posttranslational Modification
5%
Promoter Region
10%
Proteogenomics
48%
Proteome
5%
Proteomics
33%
Pseudoknot
7%
Receptor Tyrosine Kinase
5%
RNA
25%
RNA Sequence
19%
RNA Sequencing
11%
Single-Nucleotide Polymorphism
19%
Somatic Mutation
42%
T Cell
8%
Tamsulosin
14%
Telomerase
5%
Transcription Factors
7%
Transcriptome
15%
Transcriptomics
18%
Tumor Progression
12%
Tumor Suppressor Protein
7%
Wart Virus
7%
Whole Genome Sequencing
42%